Latest Ludwig-McGill HPV Cohort Stories

2008-12-03 14:57:00

Australian researchers said on Wednesday that a study of Merck & Co Inc's cervical cancer vaccine Gardasil found that allergic reactions were uncommon and most young women can tolerate subsequent doses. The study closely examined 25 Australian girls with suspected hypersensitivity to the vaccine which was administered as part of a national immunization program to all females aged 12 to 26 in the country beginning in 2007. Sharon Choo of the Royal Children's Hospital in Melbourne and...

2008-10-17 06:00:06

By Generic For most women, it's a choice whether or not they want Gardasil -- a vaccine that protects against the sexually transmitted human papillomavirus (HPV). Not so for immigrant families with young daughters who are applying for U.S. citizenship. The only choice they have is to either abide by the mandate or give up their American Dream. A 12-year-old immigration law boils down vaccine requirements for green-card applicants to an issue of semantics. Accordingly, vaccines merely...

2008-10-10 21:00:02

One in four teenage girls received at least one dose of a relatively new vaccine against cervical cancer, U.S. health officials said. The 25.1 percent vaccination rate among 13- to 17-year-olds provides the first national estimate of use of Merck & Co.'s Gardasil vaccine, the Centers for Disease Control and Prevention said. Gardasil, administered in a three-dose series, is a vaccine against certain types of human papillomavirus, which infects the skin and mucous membranes. Human...

2008-10-06 18:00:36

VENLO, Netherlands, Oct. 6 /PRNewswire/ -- The Nobel Prize-winning discovery of the causal link between human papillomavirus (HPV) and cervical cancer has spurred lifesaving prevention technologies -- such as HPV testing and HPV vaccines -- that are helping to eradicate cervical cancer globally. The Nobel Prize Committee today announced that Professor Harald zur Hausen at the German Cancer Research Center in Heidelberg will receive this year's Nobel Prize in Medicine/Physiology for the...

2008-08-21 06:00:19

By Elisabeth Rosenthal In two years, cervical cancer has gone from obscure killer confined mostly to poor nations to the West's disease of the moment. Tens of millions of girls and young women in the United States and Europe have been vaccinated against a virus that can cause many types of the disease in the two years since two vaccines were given government approval in many countries and, often, recommended for universal use among females ages 11 to 26. One of the vaccines, Gardasil,...

2005-06-14 11:49:24

LONDON (Reuters) -- Microsoft Corp founder Bill Gates is putting his financial muscle behind a campaign to get life-saving cervical cancer vaccines to women in poor countries. Two rival vaccines targeting the human papillomavirus (HPV), which causes the disease, are expected to be launched in the next year or two by Merck & Co Inc and GlaxoSmithKline Plc. But it is unclear how the novel shots will be funded in the developing world, where most deaths from cervical cancer occur. In a bid to...

Word of the Day
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.